Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613

Watchlist Manager
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Logo
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
Watchlist
Price: 6.07 CNY 0.33% Market Closed
Market Cap: 3.2B CNY

Relative Value

The Relative Value of one Shanghai Shenqi Pharmaceutical Investment Management Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 6.07 CNY, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
59
Median 3Y
1.7
Median 5Y
1.5
Industry
2.6
vs History
52
vs Industry
6
Median 3Y
58.9
Median 5Y
52.8
Industry
21.4
vs History
41
vs Industry
29
Median 3Y
16.7
Median 5Y
16.7
Industry
16.4
vs History
33
vs Industry
21
Median 3Y
23.2
Median 5Y
23.8
Industry
22.8
vs History
22
vs Industry
50
Median 3Y
0
Median 5Y
0
Industry
2.2
vs History
30
vs Industry
66
Median 3Y
1.8
Median 5Y
1.5
Industry
2.9
vs History
15
vs Industry
63
Median 3Y
3.7
Median 5Y
3.1
Industry
5.5
vs History
50
vs Industry
10
Median 3Y
41.7
Median 5Y
39.2
Industry
13
vs History
50
vs Industry
12
Median 3Y
41.7
Median 5Y
39.2
Industry
16.5
vs History
36
vs Industry
34
Median 3Y
17.6
Median 5Y
17.6
Industry
15.6
vs History
41
vs Industry
28
Median 3Y
20.3
Median 5Y
21.8
Industry
18.7
vs History
22
vs Industry
49
Median 3Y
0
Median 5Y
0
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
3.2B CNY 1.7 52 39.2 39.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.3 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
CN
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
Average P/E: 27.4
52
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5